Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2017

  • ID: 4377420
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2017, provides comprehensive insights into Chronic Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Chronic Myeloid Leukemia market size and drug sales. This research also provides insights into Chronic Myeloid Leukemia epidemiology and late stage pipeline.

The report is classified into nine sections - Chronic Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Chronic Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Chronic Myeloid Leukemia prevalence trends by countries; Chronic Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Chronic Myeloid Leukemia pipeline: Find out the drugs in clinical trials for Chronic Myeloid Leukemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Chronic Myeloid Leukemia epidemiology: Find out the prevalence of Chronic Myeloid Leukemia by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Chronic Myeloid Leukemia products: Identify key products marketed and prescribed for Chronic Myeloid Leukemia by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Myeloid Leukemia market size: Find out the market size for Chronic Myeloid Leukemia drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Chronic Myeloid Leukemia drug sales: Find out the sales of Chronic Myeloid Leukemia drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Chronic Myeloid Leukemia drugs sales forecast: Sales forecast for Chronic Myeloid Leukemia drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Myeloid Leukemia market share analysis: Find out the market shares of Chronic Myeloid Leukemia drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Chronic Myeloid Leukemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Chronic Myeloid Leukemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Chronic Myeloid Leukemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Chronic Myeloid Leukemia: Disease Overview
1.1. Chronic Myeloid Leukemia Symptoms
1.2. Chronic Myeloid Leukemia Etiology
1.3. Chronic Myeloid Leukemia Diagnosis
1.4. Chronic Myeloid Leukemia Treatment Options

2. Chronic Myeloid Leukemia Pipeline Insights
2.1. Chronic Myeloid Leukemia Phase 3 Clinical Trials
2.2. Chronic Myeloid Leukemia Phase 2 Clinical Trials
2.3. Chronic Myeloid Leukemia Phase 1 Clinical Trials

3. Chronic Myeloid Leukemia Epidemiology Analysis

4. Germany Chronic Myeloid Leukemia Market Insights
4.1. Marketed Products for Chronic Myeloid Leukemia in Germany
4.2. Germany Chronic Myeloid Leukemia Market Size & Forecast
4.3. Germany Chronic Myeloid Leukemia Product Sales Forecast
4.4. Germany Chronic Myeloid Leukemia Market Share Analysis

5. France Chronic Myeloid Leukemia Market Insights
5.1. Marketed Products for Chronic Myeloid Leukemia in France
5.2. France Chronic Myeloid Leukemia Market Size & Forecast
5.3. France Chronic Myeloid Leukemia Product Sales Forecast
5.4. France Chronic Myeloid Leukemia Market Share Analysis

6. Italy Chronic Myeloid Leukemia Market Insights
6.1. Marketed Products for Chronic Myeloid Leukemia in Italy
6.2. Italy Chronic Myeloid Leukemia Market Size & Forecast
6.3. Italy Chronic Myeloid Leukemia Product Sales Forecast
6.4. Italy Chronic Myeloid Leukemia Market Share Analysis

7. Spain Chronic Myeloid Leukemia Market Insights
7.1. Marketed Products for Chronic Myeloid Leukemia in Spain
7.2. Spain Chronic Myeloid Leukemia Market Size & Forecast
7.3. Spain Chronic Myeloid Leukemia Product Sales Forecast
7.4. Spain Chronic Myeloid Leukemia Market Share Analysis

8. UK Chronic Myeloid Leukemia Market Insights
8.1. Marketed Products for Chronic Myeloid Leukemia in UK
8.2. UK Chronic Myeloid Leukemia Market Size & Forecast
8.3. UK Chronic Myeloid Leukemia Product Sales Forecast
8.4. UK Chronic Myeloid Leukemia Market Share Analysis

9. Europe Chronic Myeloid Leukemia Market Insights
9.1. Europe Chronic Myeloid Leukemia Market Size & Forecast
9.2. Europe Chronic Myeloid Leukemia Product Sales Forecast
9.3. Europe Chronic Myeloid Leukemia Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Chronic Myeloid Leukemia Phase 3 Clinical Trials, Global, 2017
Table 2: Chronic Myeloid Leukemia Phase 2 Clinical Trials, Global, 2017
Table 3: Chronic Myeloid Leukemia Phase 1 Clinical Trials, Global, 2017
Table 4: Chronic Myeloid Leukemia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Chronic Myeloid Leukemia in Germany, 2017
Table 6: Germany Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 8: Germany Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 9: Marketed Products for Chronic Myeloid Leukemia in France, 2017
Table 10: France Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 12: France Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 13: Marketed Products for Chronic Myeloid Leukemia in Italy, 2017
Table 14: Italy Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 16: Italy Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 17: Marketed Products for Chronic Myeloid Leukemia in Spain, 2017
Table 18: Spain Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 20: Spain Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 21: Marketed Products for Chronic Myeloid Leukemia in UK, 2017
Table 22: UK Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 24: UK Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 25: Europe Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Chronic Myeloid Leukemia Pipeline by Phase (%), Global, 2017
Figure 2: Chronic Myeloid Leukemia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 4: Germany Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 6: Germany Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 7: France Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 8: France Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 9: France Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 10: France Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 11: Italy Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 12: Italy Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 14: Italy Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 15: Spain Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 16: Spain Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 18: Spain Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 19: UK Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 20: UK Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 21: UK Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 22: UK Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 23: Europe Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 24: Europe Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 26: Europe Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll